Safety of Nifedipine in Angina Pectoris: A Meta-Analysis

Hypertension

Volumn 33, Issue 1, 1999, Pages 24-31

  Stason, William B ^a   Schmid, Christopher H ^a   Niedzwiecki, Donna ^a   Whiting, Gregory W ^a   Caubet, Jean Francois ^a   Cory, Douglas ^a   Luo, Don ^a   Ross, Susan D ^a   Chalmers, Thomas C ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; NIFEDIPINE;

ACUTE HEART INFARCTION; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EDEMA; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE; SUSTAINED RELEASE PREPARATION;

ADRENERGIC BETA-ANTAGONISTS; ANGINA PECTORIS; CALCIUM CHANNEL BLOCKERS; DELAYED-ACTION PREPARATIONS; DOSAGE FORMS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NIFEDIPINE; NITRATES; ODDS RATIO; PLACEBOS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SAFETY; TIME FACTORS; VASODILATOR AGENTS;

EID: 0032890905     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.33.1.24     Document Type: Article

References (79)

1. Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995;92:1326-1331.
2. Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, Rosendaal FR, Lemaitre RN, Smith NL, Wahl PW. The risk of myocardial infarction associated with anti-hypertensive drug therapies. JAMA. 1995;274:620-625.
3. Dahlof B, Hansson L, Lindholm LH, Schersten B, Wester PO, Ekbom T, Hedner T, de Faire U. STOP-Hypertension 2: a prospective intervention trial of newer versus older treatment alternatives in old patients with hypertension: Swedish Trial in Old Patients with Hypertension. Blood Press. 1993;2:136-141.
4. Amery A, Birkenhager W, Bulpitt CJ, Clement D, De Leeuw P, Dollery CT, Fagard R, Fletcher A, Forette F, Leonetti G. Syst-Eur: A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol and organization. Aging (Milano). 1991;3:287-302.
5. The NORDIL Group. The Nordic Diltiazem Study (NORDIL): a prospective intervention trial of calcium antagonist therapy in hypertension. Blood Press. 1992;2:314-321.
6. Davis BR, Cutler JA, Gordon DJ, Furberg CD, Wright JT Jr, Cushman WC, Grimm RH, LaRosa J, Whelton PK, Perry HM, Alderman MH, Ford CE, Oparil S, Francis C, Proschan M, Pressel S, Black HR, Hawkins CM. Rationale and design for the Anti-hypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Am J Hypertens. 1996;9:342-360.
7. Stason WB, Schmid CH, Niedzwiecki D, Whiting GW, Luo D, Ross SD, Chalmers TC. Safety of nifedipine in patients with hypertension. Hypertension. 1997;30(pt 1):7-14.
8. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analysis of randomized controlled trials. N Engl J Med. 1987;316:450-455.
9. Chalmers TC, Smith H Jr, Blackburn B, Silverman B, Schroeder B, Reitman D, Ambroz A. A method for assessing the quality of a randomized control trial. Control Clin Trials. 1981;2:31-49.
10. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomised clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-2.
11. SAS Institute. SAS/STAT Users Guide. Cary, NC: SAS Institute; 1989:1071-1126.
12. DerSimonian R, Laird NM. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
13. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of randomized trials. Prog Cardiovasc Dis. 1985;27:335-371.
14. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons; 1989.
15. Akhras F, Chambers J, Jefferies S, Jackson G. A randomised double-blind crossover study of isosorbide mononitrate and nifedipine retard in chronic stable angina. Int J Cardiol. 1989;24:191-196.
16. Akhras F, Jackson G. Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina. Lancet. 1991;338:1036-1039.
17. Ankier SI, Fay L, Warrington SJ, Woodings DF. A multicentre open comparison of isosorbide-5-mononitrate and nifedipine given prophylactically to general practice patients with chronic stable angina pectoris. J Int Med Res. 1989;17:172-178.
18. Ardissino D, Savonitto S, Egstrup K, Marraccini P, Slavich G, Rosenfeld M, Feruglio GA, Roncarolo P, Giordano MP, Wahlqvist I. Transient myocardial ischemia during daily life in rest and exertional angina pectoris and comparison of effectiveness of metoprolol versus nifedipine. Am J Cardiol. 1991;67:946-952.
19. Ardissino D, Savonitto S, Egstrup K, Rasmussen K, Bae EA, Omland T, Schjelderup-Mathiesen PM, Marraccini P, Merlini PA, Wahlqvist I. Selection of medical treatment in stable angina pectoris: results of the International Multicenter Angina Exercise (IMAGE) Study. J Am Coll Cardiol. 1995;25:1516-1521.
20. Aschermann M, Bultas J, Karetova D, Kolbel F, Kozakova M, Simper D. Randomized double-blind comparison of isosorbide dinitrate and nifedipine in variant angina pectoris. Am J Cardiol. 1990;65:46J-49J.
21. Bailey JS. The prophylaxis of angina pectoris in general practice: a placebo-controlled comparison of nifedipine and propranolol. Practitioner. 1982;226:343-345.
22. Blake P, Berry SC, Readman A, Ratcliffe M, Godley M. A comparison of epanolol and nifedipine in stable angina patients: results of a multicentre trial. Cardiology. 1991;79:249-255.
23. Bohm C, Christl HL, Wald G. Drug therapy of coronary heart disease: comparative effects of nifedipine and isosorbide dinitrate. Med Welt. 1982;33:1242-1244.
24. Chung M, Reitberg DP, Gaffney M, Singleton W. Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system: a controlled-release formulation of nifedipine. Am J Med. 1987;83:10-14.
25. Cocco G, Strozzi C, Chu D, Amrein R, Castagnoli E. Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia. Eur J Cardiol. 1979;10:59-69.
26. Crake T, Mulcahy D, Wright C, Fox K. Labetalol in the treatment of stable exertional angina pectoris: a comparison with nifedipine. Eur Heart J. 1988;9:1200-1205.
27. Dalla-Volta S, Maraglino G, Della-Valentina P, Viena P, Desideri A. Comparison of trimetazidine with nifedipine in effort angina: a double-blind, crossover study. Cardiovasc Drugs Ther. 1990;4(suppl 4):853-859.
28. Dawson JR, Whitaker NH, Sutton GC. Calcium antagonist drugs in chronic stable angina: comparison of verapamil and nifedipine. Br Heart J. 1981;46:508-512.
29. Deedwania PC, Carbajal EV, Nelson JR, Hait H. Anti-ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischemia. J Am Coll Cardiol. 1991;17:963-969.
30. Di Pasquale G, Lusa AM, Manini GL, Coluccini M, Bassein L, Pinelli G. Comparative efficacy of nicardipine, a new calcium antagonist, versus nifedipine in stable effort angina. Int J Cardiol. 1984;6:673-688.
31. Donaldson KM, Dawkins KD, Waller DG. A comparison of nisoldipine and nifedipine, in combination with atenolol, in the management of myocardial ischaemia. Eur Heart J. 1993;14:534-539.
32. Egstrup K. Randomized double-blind comparison of metoprolol, nifedipine, and their combination in chronic stable angina: effects on total ischemic activity and heart rate at onset of ischemia. Am Heart J. 1988;116:971-978.
33. Ekelund LG, Oro L. Antianginal efficiency of nifedipine with and without a beta-blocker, studied with exercise test: a double-blind, randomized subacute study. Clin Cardiol. 1979;2:203-211.
34. Foale RA. Atenolol versus the fixed combination of atenolol and nifedipine in stable angina pectoris. Eur Heart J. 1993;14:1369-1374.
35. Foale RA, Vandenburg MJ. Sustained-release verapamil and nifedipine in exercise-induced angina pectoris. Eur Heart J. 1992;13:256-260.
36. Frishman WH, Cheng A: Secondary prevention of myocardial infarction: Role of beta-adrenergic blockers and angiotensin-converting enzyme inhibitors. Am Heart J 1999;137(4 suppl):S25-S34.
37. Frishman WH, Charlap S, Kimmel B, Teicher M, Cinnamon J, Allen L, Strom J. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment. Circulation. 1988;77:774-786.
38. Ginsburg R, Lamb IH, Schroeder IS, Hu M, Harrison DC. Randomized double-blind comparison of nifedipine and isosorbide dinitrate therapy in variant angina pectoris due to coronary artery spasm. Am Heart J. 1982;103:44-49.
39. Gruppillo P, Battaglia R, Masoni C, Maistrello I, Masoni A. Therapeutical comparison between atenolol and nifedipine in effort angina (author's translation). G Ital Cardiol. 1981;11:2081-2087.
40. Harris L, Dargie HJ, Lynch PG, Bulpitt CJ, Krikler DM. Blood pressure and heart rate in patients with ischaemic heart disease receiving nifedipine and propranolol. BMJ (Clin Res Ed). 1982;284:1148-1151.
41. Higginbotham MB, Morris KG, Coleman RE, Cobb FR. Chronic stable angina monotherapy: nifedipine versus propranolol. Am J Med. 1989;86:1-5.
42. Hill JA, Gonzalez JI, Kolb R, Pepine CJ. Effects of atenolol alone, nifedipine alone and their combination on ambulant myocardial ischemia. Am J Cardiol. 1991;67:671-675.
43. Johnston DL, Lesoway R, Humen DP, Kostuk WJ. Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: a placebo-controlled, double-blind, randomized, crossover study. Am J Cardiol. 1985;55:680-687.
44. Kawanishi DTLC, SH. Response of angina and ischemia to long-term treatment in patients with chronic stable angina: a double-blind randomized individualized dosing trial of nifedipine, propranolol and their combination. J Am Coll Cardiol. 1992;19:409-417.
45. Klein W, Brandt D, Fluch N, Maurer E. Treatment of stable exercise angina with calcium blockers-a double-blind, placebo-controlled comparison of diltiazem and nifedipine [in German]. Z Kardiol. 1982;71:398-405.
46. Kleinbloesem CH, van Brummeien P, van de Linde JA, Voogd PJ, Breimer DD. Nifedipine: kinetics and dynamics in healthy subjects. Clin Pharmacol Ther. 1984;35:742-749.
47. Kleinbloesem CH, van Brummelen P, Danhof M, Faber H, Urquhart J, Breimer DD. Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans. Clin Pharmacol Ther. 1987;41:26-30.
48. Klinke WP, Kvill L, Dempsey EE, Grace M. A randomized double-blind comparison of diltiazem and nifedipine in stable angina. J Am Coll Cardiol. 1988;12:1562-1567.
49. Lazzeroni E, Morozzi L, Campana M, Botti G. Efficacy and tolerability of gallopamil in coronary heart disease: a double blind cross-over comparison with nifedipine. Eur Heart J. 1992;13:526-530.
50. Liang CS, Coplin B, Wellington K. Comparison of antianginal efficacy of nifedipine and isosorbide dinitrate in chronic stable angina: a long-term, randomized, double-blind, crossover study. Am J Cardiol. 1985;55:9E-14E.
51. Lynch P, Dargie H, Krikler S, Krikler D. Objective assessment of anti-anginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination. BMJ. 1980;281:184-187.
52. Meluzin J, Zeman K, Stetka F, Simek P. Effects of nifedipine and diltiazem on myocardial ischemia in patients with severe stable angina pectoris treated with nitrates and beta-blockers. J Cardiovasc Pharmacol. 1992;20:864-869.
53. Morse JR. Comparison of combination nifedipine-propranolol and diltiazem-propranolol with high dose diltiazem monotherapy for stable angina pectoris. Am J Cardiol. 1988;62:1028-1032.
54. Nesto RW, Phillips RT, Kett KG, McAuliffe LS, Roberts M, Hegarty P. Effect of nifedipine on total ischemic activity and circadian distribution of myocardial ischemic episodes in angina pectoris. Am J Cardiol. 1991;67:128-132.
55. Pitcher D, Sowton E. Double-blind trial of nifedipine in angina patients with normal coronary arteries. Pharmatherapeutica. 1981;3:6-13.
56. Prida XE, Gelman JS, Feldman RL, Hill JA, Pepine CJ, Scott E. Comparison of diltiazem and nifedipine alone and in combination in patients with coronary artery spasm. J Am Coll Cardiol. 1987;9:412-419.
57. Regoli F, Giusti C. Dilazep vs. nifedipine in patients with stable effort angina: a double blind randomized study (author's translation). G Ital Cardiol. 1981;11:2097-2104.
58. Rettig G, Sen S, Vogel W, Heisel A, Schieffer H, Bette L. Antianginal efficacy of gallopamil in comparison to nifedipine. Int J Cardiol. 1988;19:315-325.
59. Rettig GF, Jakob M, Koch HP. The anti-ischemic effect of gallopamil-retard in comparison with nifedipine-retard in stable angina pectoris. Z Kardiol. 1992;81:525-530.
60. Robinson K, Krikler S, Krikler DM. Comparative study of the effect of nifedipine versus diltiazem on exercise performance, serum propranolol levels, and ST-segment abnormalities in patients with chronic stable angina taking propranolol. Am J Cardiol. 1989;64:27F-30F.
61. Ruzicka M, Leenen FHH. Relevance of intermittent increases in sympathetic activity for adverse outcome on short-acting calcium antagonists. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York, NY: Raven Press Ltd; 1995;2815-2825.
62. Scardi S, Borgioni L, Alberti E, Palmieri M, Passarelli A, Ruggeri G, Zappala A, Baroni F, Camerini F. Controlled clinical trial of 5 antianginal treatments. G Ital Cardiol. 1978;8:587-600.
63. Schulte KL. Twenty-four h anti-anginal and anti-ischaemic effects with once daily felodipine: a double-blind comparison with nifedipine, twice daily, and placebo in patients with stable exercise induced angina pectoris. Eur Heart J. 1995;16:171-176.
64. Shapiro W, Narahara KA, Kostis JB, Thandroyen F, Zohman LR. Comparison of atenolol and nifedipine in chronic stable angina pectoris. Am J Cardiol. 1989;64:186-190.
65. Sherman LG, Liang CS. Nifedipine in chronic stable angina: a double-blind placebo-controlled crossover trial. Am J Cardiol. 1983;51:706-711.
66. Siu SC, Jacoby RM, Phillips RT, Nesto RW. Comparative efficacy of nifedipine gastrointestinal therapeutic system versus diltiazem when added to beta blockers in stable angina pectoris. Am J Cardiol. 1993;71:887-892.
67. Stone PH, Gibson RS, Glasser SP, DeWood MA, Parker JD, Kawanishi DT, Crawford MH, Messineo FC, Shook TL, Raby K, for the ASIS Study Group. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina: differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. Circulation. 1990;82:1962-1972.
68. Stone PH, Ware JH, DeWood MA, Gore JM, Eich RH, Pietro DA, Parisi AF, Nesto RW, Boden WE, Sharma SC. The efficacy of the addition of nifedipine in patients with mixed angina compared to patients with classic exertional angina: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Am Heart J. 1988;116:961-971.
69. Subramanian VB, Bowles MJ, Khurmi NS, Davies AB, Raftery EB. Randomized double-blind comparison of verapamil and nifedipine in chronic stable angina. Am J Cardiol. 1982;50:696-703.
70. Toyosaki N, Toyo-oka T, Natsume T, Katsuki T, Tateishi T, Yaginuma T, Hosoda S. Combination therapy with diltiazem and nifedipine in patients with effort angina pectoris. Circulation. 1988;77:1370-1375.
71. Tweddel AC, Beattie JM, Murray RG, Hutton I. The combination of nifedipine and propranolol in the management of patients with angina pectoris. Br J Clin Pharmacol. 1981;12:229-233.
72. Uusitalo A, Arstila M, Bae EA, Harkonen R, Keyrilainen O, Rytkonen U, Schjelderup-Mathiesen PM, Wendelin H. Metoprolol, nifedipine, and the combination in stable effort angina pectoris. Am J Cardiol. 1986;57:733-737.
73. van der Does R, Eberhardt R, Derr I, Ehmer B, Rudorf J, Uberbacher HJ. Treatment of chronic stable angina with carvedilol in comparison with nifedipine s.r. Eur Heart J. 1991;12:60-64.
74. Villalpando Gutierrez J, Navarro Robles J, Necoechea Alva JC, Aceves Miramontes C, Parcero Valdez JJ. A comparative clinical study of calcium blockers, gallopamil and nifedipine, in the treatment of stable chest angina. Arch Inst Cardiol Mex. 1990;60:71-77.
75. Dargie HJ, Ford I, Fox KM, on behalf of the TIBET Study Group. Total Ischaemic Burden European Trial (TIBET): effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. Eur Heart J. 1996;17:104-112.
76. von Arnim T, for the TIBBS Investigators. Medical treatment to reduce total ischemic burden: Total Ischemic Burden Bisoprolol Study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine. J Am Coll Cardiol. 1995;25:231-238.
77. Wallace WA, Wellington KL, Chess MA, Liang CS. Comparison of nifedipine gastrointestinal therapeutic system and atenolol on antianginal efficacies and exercise hemodynamic responses in stable angina pectoris. Am J Cardiol. 1994;73:23-28.
78. Wallace WA, Wellington KL, Murphy GW, Liang CS. Comparison of antianginal efficacies and exercise hemodynamic effects of nifedipine and diltiazem in stable angina pectoris. Am J Cardiol. 1989;63:414-418.
79. Winniford MD, Fulton KL, Corbett JR, Croft CH, Hillis LD. Propranolol-verapamil versus propranolol-nifedipine in severe angina pectoris of effort: a randomized, double-blind, crossover study. Am J Cardiol. 1985;55:281-285.